For example, non-coding mutation hotspots upstream of TAL1 and LMO1 in T-cell acute lymphoblastic leukemia lead to the formation of de novo MYB binding sites that drives the overexpression of TAL1 and LMO1 oncogenes10,11. This evidence concerns the gene TAL1 and T-cell acute lymphoblastic leukemia.